Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome

MLA

Tadashi Nakajima, et al. “Functionally Validated SCN5A Variants Allow Interpretation of Pathogenicity and Prediction of Lethal Events in Brugada Syndrome.” European Heart Journal, vol. 42, June 2021, pp. 2854–63. EBSCOhost, https://doi.org/10.1093/eurheartj/ehab254.

APA

Tadashi Nakajima, Soshiro Ogata, Naomasa Makita, Shiro Kamakura, Minoru Horie, Jean-Jacques Schott, Takeshi Aiba, Kengo Kusano, Satoshi Nagase, Masahiko Takagi, Hiroyuki Mishima, Koh-ichiro Yoshiura, Kenichiro Yamagata, Hiroshi Morita, Matilde Karakachoff, Taisuke Ishikawa, Nobuyuki Murakoshi, Kimie Ohkubo, Kunihiro Nishimura, … Akihiko Nogami. (2021). Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome. European Heart Journal, 42, 2854–2863. https://doi.org/10.1093/eurheartj/ehab254

Chicago

Tadashi Nakajima, Soshiro Ogata, Naomasa Makita, Shiro Kamakura, Minoru Horie, Jean-Jacques Schott, Takeshi Aiba, et al. 2021. “Functionally Validated SCN5A Variants Allow Interpretation of Pathogenicity and Prediction of Lethal Events in Brugada Syndrome.” European Heart Journal 42 (June): 2854–63. doi:10.1093/eurheartj/ehab254.